Blue Jet Healthcare Ltd — earnings calls
2 quarters summarised from transcripts filed with the exchange, every statement cited. Newest first.
Blue Jet Healthcare reported Q1 FY27 revenue of INR293 crores, up 25% sequentially, with operating EBITDA margin of 33.5% versus 30.4% in the prior quarter. Management attributed the improvement to stronger PI/API vertical performance following normalization of customer inventory, while contrast media revenue declined due to goods-in-transit recognition delays from container availability and geopolitical disruptions. The company also detailed progress on its Vizag expansion, Unit 3 backward integration project, and a new Hyderabad R&D center expected to become operational during the month.
Blue Jet Healthcare reported Q4 FY26 revenue of Rs 235 crore, up 22% quarter-over-quarter but down 31% year-over-year, while full-year FY26 revenue of Rs 947 crore declined 8% versus FY25 as the PI/API segment was hit by customer destocking. The contrast media segment grew 23% for the full year on strong customer offtake, partly offsetting weakness in PI/API and artificial sweeteners. Management described progress on the Vizag greenfield project, the Mahad backward integration, and a new Hyderabad R&D center, and said it expects improved visibility heading into FY27.